ACT-541468: Clinical Trials

1 trial of ACT-541468, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow ACT-541468: new trials by email Literature Review of ACT-541468 trials Research Report on ACT-541468

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
ACT-541468, Placebo - Insomnia Disorder
Phase 2CompletedIdorsia Pharmaceuticals Ltd.582016-11-282020-04-24

Conditions studied

Sleep Initiation and Maintenance Disorders (1)

Sponsors

Idorsia Pharmaceuticals Ltd. (1)

Countries

Germany (1)  ·  United States (1)

Results publications

PMID 32341187